BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21554219)

  • 21. Adaptation and Validation of a Pediatric Sequential Organ Failure Assessment Score and Evaluation of the Sepsis-3 Definitions in Critically Ill Children.
    Matics TJ; Sanchez-Pinto LN
    JAMA Pediatr; 2017 Oct; 171(10):e172352. PubMed ID: 28783810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers Predicting Tissue Pharmacokinetics of Antimicrobials in Sepsis: A Review.
    Sanz Codina M; Zeitlinger M
    Clin Pharmacokinet; 2022 May; 61(5):593-617. PubMed ID: 35218003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using PK/PD to optimize antibiotic dosing for critically ill patients.
    Roberts JA
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2070-9. PubMed ID: 21554211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma and interstitial fluid population pharmacokinetics of vancomycin in critically ill patients with sepsis.
    Abraham J; Sinnollareddy MG; Roberts MS; Williams P; Peake SL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2019 Feb; 53(2):137-142. PubMed ID: 30296581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sepsis in the critically-ill patient].
    Christensen VB; Nielsen JS; Tønnesen EK
    Ugeskr Laeger; 2007 Feb; 169(8):703-5. PubMed ID: 17313921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sepsis and SOFA score: related outcome for critically ill renal patients.
    Carbonell N; Blasco M; Ferreres J; Blanquer J; García-Ramón R; Mesejo A; Miguel A
    Clin Nephrol; 2004 Sep; 62(3):185-92. PubMed ID: 15481850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of antimicrobial drugs in intensive care unit patients.
    Macedo RS; Onita JH; Wille MP; Furtado GH
    Shock; 2013 May; 39 Suppl 1():24-8. PubMed ID: 23481498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.
    Abdul-Aziz MH; Sulaiman H; Mat-Nor MB; Rai V; Wong KK; Hasan MS; Abd Rahman AN; Jamal JA; Wallis SC; Lipman J; Staatz CE; Roberts JA
    Intensive Care Med; 2016 Oct; 42(10):1535-1545. PubMed ID: 26754759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes.
    Bagshaw SM; Uchino S; Bellomo R; Morimatsu H; Morgera S; Schetz M; Tan I; Bouman C; Macedo E; Gibney N; Tolwani A; Oudemans-van Straaten HM; Ronco C; Kellum JA;
    Clin J Am Soc Nephrol; 2007 May; 2(3):431-9. PubMed ID: 17699448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission: results from The Intensive Care Over Nations audit.
    Peters E; Antonelli M; Wittebole X; Nanchal R; François B; Sakr Y; Vincent JL; Pickkers P
    Crit Care; 2018 Aug; 22(1):188. PubMed ID: 30075798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluid balance in sepsis and septic shock as a determining factor of mortality.
    Sirvent JM; Ferri C; Baró A; Murcia C; Lorencio C
    Am J Emerg Med; 2015 Feb; 33(2):186-9. PubMed ID: 25483379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemostasis and endothelial damage during sepsis.
    Johansen ME
    Dan Med J; 2015 Aug; 62(8):B5135. PubMed ID: 26239597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients.
    Kaska M; Havel E; Selke-Krulichova I; Safranek P; Bezouska J; Martinkova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):219-226. PubMed ID: 29582860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012.
    Kaukonen KM; Bailey M; Suzuki S; Pilcher D; Bellomo R
    JAMA; 2014 Apr; 311(13):1308-16. PubMed ID: 24638143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Pharmacology Studies in Critically Ill Children.
    Thakkar N; Salerno S; Hornik CP; Gonzalez D
    Pharm Res; 2017 Jan; 34(1):7-24. PubMed ID: 27585904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Septic acute kidney injury in critically ill patients - a single-center study on its incidence, clinical characteristics, and outcome predictors.
    Shum HP; Kong HH; Chan KC; Yan WW; Chan TM
    Ren Fail; 2016 Jun; 38(5):706-16. PubMed ID: 26981621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver dysfunction in sepsis.
    Woźnica EA; Inglot M; Woźnica RK; Łysenko L
    Adv Clin Exp Med; 2018 Apr; 27(4):547-551. PubMed ID: 29558045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluid resuscitation and the septic kidney.
    Bagshaw SM; Bellomo R
    Curr Opin Crit Care; 2006 Dec; 12(6):527-30. PubMed ID: 17077681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children.
    Leclerc F; Leteurtre S; Duhamel A; Grandbastien B; Proulx F; Martinot A; Gauvin F; Hubert P; Lacroix J
    Am J Respir Crit Care Med; 2005 Feb; 171(4):348-53. PubMed ID: 15516535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
    Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.